Are CGDV and IBB in the same category?

CGDV is a stock ETF and IBB is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.

Which returned more over the last year, CGDV or IBB?

In the year to Oct 28, 2026, with distributions reinvested, CGDV returned +15.8% and IBB +37.5%.

Which is cheaper, CGDV or IBB?

CGDV is cheaper, by 0.11 percentage points a year. That is about $11 on $10,000 held for a year. Fees come from each fund's prospectus.

How much do CGDV and IBB overlap with the S&P 500?

By their latest filed holdings, 92% of CGDV and 40% of IBB by weight is stocks the S&P 500 already holds.

Data as of Oct 28, 2026.

Across categories

CGDV vs IBB: Differences, Returns & Fees

Share on X Download as PDF

Over the year to Oct 28, 2026, CGDV returned +15.8% to IBB's +37.5%, and CGDV charges 0.33% to IBB's 0.44%.

askIQ about this page

askIQ about CGDV and IBB

Net assets on Oct 27, 2026: $39.1bn for Capital Group Dividend Value ETF and $11.0bn for iShares Biotechnology ETF.

CGDV on its own →IBB on its own →

At a glance

+15.8%

CGDV total return, 1 year

+37.5%

IBB total return, 1 year

0.33%

CGDV expense ratio

0.44%

IBB expense ratio

Pair scorecard

CGDV costs 0.11 points a year less; their one-year returns differ by 21.7 points; CGDV is 3.6 times larger.

CGDV vs IBB: Differences, Returns & Fees
Measure	CGDV	IBB
Return
Measure	CGDV	IBB
Total return, 1 year	+15.8%	+37.5%
Drawdown
Measure	CGDV	IBB
Below its high	3.6%, high on Aug 13, 2026
Benchmark
Measure	CGDV	IBB
What it tracks	No index, actively managed	Biotech
Cost and size
Measure	CGDV	IBB
Expense ratio	0.33%	0.44%
Net assets, as of Oct 27, 2026	$39.1bn	$11.0bn
Active share vs the S&P 500		99%
Holdings
Measure	CGDV	IBB
Holdings in common	2%
Top ten holdings, share of the fund	42.0%	50%

Holdings in common uses holdings dated Aug 31, 2026 and Oct 27, 2026. Method

What they share

By the books each fund has filed, CGDV and IBB hold 2% of their money in the same securities at the same weight. Holdings dated Aug 31, 2026 and Oct 27, 2026.

50%

0 half 100%

half

2% in common

Positions both hold · largest shared weight first CGDV IBB

Amgen Inc 0.98% 8.20%

Vertex Pharmaceuticals Inc 0.79% 7.53%

Only in one fund ↓

Only in CGDV

Microsoft Corp 7.64%

NVIDIA Corp 6.32%

Broadcom Inc 4.67%

Meta Platforms Inc 4.27%

Alphabet Inc 3.55%

Royal Caribbean Cruises Ltd 3.49%

Oracle Corp 3.22%

RTX Corp 3.16%

Only in IBB

GILEAD SCIENCES 8.56%

REGENERON PHARMACEUTICALS 5.64%

MODERNA 5.29%

NATERA 3.85%

ARGENX SE ADR 3.42%

ILLUMINA INC 2.93%

BIOGEN 2.58%

REVOLUTION MEDICINES 2.50%

Check overlap with more funds →

Side by side

CGDV Capital Group Dividend Value ETF IBB iShares Biotechnology ETF

Where it sits Stock ETF Thematic ETF

Issuer Capital Group iShares

What it is Actively managed Biotech

Total return, 1 year +15.8% +37.5%

Its benchmark over the same days +27.5% (IWD) not measured

Gap to its benchmark −11.7 pts vs IWD not measured

Expense ratio 0.33% 0.44%

Already in the S&P 500 91.7% 40.2%

Holdings 53 245

Net assets, as of Oct 27, 2026 $39.1bn $11.0bn

CGDV and IBB on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

About each fund

CGDV

Over the year to Oct 28, 2026 it returned +15.8% with distributions reinvested, against +27.5% for its benchmark, the Russell 1000 Value Index.

CGDV is actively managed and tracks no index. The prospectus expense ratio is 0.33% a year. By its holdings filed for Aug 31, 2026, 92% of the fund by weight is stocks the S&P 500 also holds, across 53 positions, with the top ten at 42.0%. It sat 3.6% below its high of Aug 13, 2026 on Oct 28, 2026.

IBB

By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +37.5% with distributions reinvested.

Questions people ask

Are CGDV and IBB in the same category?: CGDV is a stock ETF and IBB is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, CGDV or IBB?: In the year to Oct 28, 2026, with distributions reinvested, CGDV returned +15.8% and IBB +37.5%.
Which is cheaper, CGDV or IBB?: CGDV is cheaper, by 0.11 percentage points a year. That is about $11 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do CGDV and IBB overlap with the S&P 500?: By their latest filed holdings, 92% of CGDV and 40% of IBB by weight is stocks the S&P 500 already holds.

Other comparisons

CGDV vs XBI AIRR vs CGDV CGDV vs GDX CGDV vs LYTE AVLV vs IBB IBB vs PVAL IBB vs SPYD FNDX vs IBB

Where to next

CGDV on its own →IBB on its own →Hold both: look the portfolio through →Rankings →CGDV dividend history →CGDV holdings →IBB dividend history →IBB holdings →Standards and sources →

Sources and dates

CGDV filings on SEC EDGAR ↗

CGDV prospectus with the expense ratio (SEC) ↗

Capital Group page for CGDV ↗

IBB filings on SEC EDGAR ↗

IBB prospectus with the expense ratio (SEC) ↗

iShares page for IBB ↗

Links are sources, not endorsements. A comparison is not a recommendation.

How this is computed

Overlap adds up the smaller of the two weights for each security both funds hold.

Cite this pageCitation, APA and Markdown

ETFIQ, CGDV against IBB, data as of Oct 28, 2026. https://etfiq.com/compare/any/cgdv-vs-ibb

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.